Log in
Enquire now
‌

US Patent 11759522 Pharmaceutical compositions comprising meloxicam

Patent 11759522 was granted and assigned to axsome therapeutics, inc. on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
axsome therapeutics, inc.
Current Assignee
‌
axsome therapeutics, inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11759522
Patent Inventor Names
Herriot Tabuteau
Date of Patent
September 19, 2023
Patent Application Number
17933703
Date Filed
September 20, 2022
Patent Citations
‌
US Patent 8835407 Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
‌
US Patent 8852636 Pharmaceutical compositions for the coordinated delivery of NSAIDs
‌
US Patent 8858996 Pharmaceutical compositions for the coordinated delivery of NSAIDS
‌
US Patent 8865190 Pharmaceutical compositions for the coordinated delivery of NSAIDs
‌
US Patent 8945621 Method for treating a patient at risk for developing an NSAID-associated ulcer
‌
US Patent 9161920 Pharmaceutical compositions for the coordinated delivery of NSAIDs
‌
US Patent 9198888 Pharmaceutical compositions for the coordinated delivery of NSAIDs
‌
US Patent 9220698 Method for delivering a pharmaceutical composition to patient in need thereof
...
Patent Citations Received
‌
US Patent 11998552 Pharmaceutical compositions comprising meloxicam
0
‌
US Patent 12128052 Pharmaceutical compositions comprising meloxicam
0
‌
US Patent 12005118 Pharmaceutical compositions comprising meloxicam
0
‌
US Patent 11801250 Pharmaceutical compositions comprising meloxicam
‌
US Patent 11944683 Pharmaceutical compositions comprising meloxicam
0
‌
US Patent 11865117 Pharmaceutical compositions comprising meloxicam
0
Patent Primary Examiner
‌
Jared Barsky
CPC Code
‌
C08B 37/0015
‌
C08B 37/0012
‌
A61K 47/40
‌
A61K 31/5415
‌
A61K 31/4439
‌
A61K 9/2009
‌
A61K 47/6951
‌
A61K 9/0053
Patent abstract

Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a T

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11759522 Pharmaceutical compositions comprising meloxicam

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.